We look at 19 stocks primed to deliver major events in their career
By the Shares team
Investors are spoiled for choice when it comes to small cap stocks with exciting events. As a taster for what’s to come in 2018, we’ve scoured the markets to look for some of the most interesting activities.
Read on to discover 19 stocks either expecting big news in the very near future or ones which are in the middle of developments which could have a big impact on their longer term prospects.
MOVING INTO NEW MARKETS
Lipstick-to-eyeshadow specialist Warpaint London (LON:W7L) is moving into the men’s market with the £18.2m acquisition of Retra. The deal, which only completed three weeks ago, is expected to enhance earnings and dividends alike. It will allow Warpaint to target male consumers and increase exposure to the attractive international gifting market.
Distributing its wares to Boots, Superdrug and Asda – new customers for Warpaint – profitable, Yorkshire-based Retra’s major brands are Technic, Body Collection and Man’s Stuff, the latter a new male grooming range spanning shower gels-to-beard oils.
Joint bosses Sam Bazini and Eoin Macleod insist Retra, which also produces white label cosmetics for Asda and Matalan, will ‘help to accelerate Warpaint’s growth both domestically and internationally’.
DRUG STOCKS AWAITING MAKE-OR-BREAK NEWS
The pharmaceuticals space in 2018 is jam-packed with potentially game-changing clinical trial results.
Drug developer ImmuPharma (LON:IMM) is expecting Phase III results in the first quarter of 2018 for lupus treatment Lupuzor. Analysts speculate the drug could hit multi-billion dollar annual sales if the tests are successful and the drug gets approved by the regulators.
